Appropriate use of immune checkpoint inhibitors and immunotherapy differs in adults with unresectable, metastatic cutaneous ...
The Company will issue a release after the oral presentation that will include the 5-year OS data, which is the longest OS follow-up in a randomized trial in metastatic uveal melanoma patients. Beyond ...
NUC-7738 Demonstrates Clinical Activity and Favorable Safety in Patients with PD-1 Inhibitor-Resistant Melanoma ...
Health economics analysis highlights the economic burden of late-stage leptomeningeal metastases (LM) and the potential value ...
A FORMER sunbed addict has revealed what her skin looked like at the height of her addiction – versus now. Mia Calver took to ...
A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how ...
Cholesterol enhances melanoma cell invasion by making nuclei squishier, revealing a potential treatment target in cancer progression.
A routine eye exam led to Cork woman Elaine O’Callaghan being diagnosed with a rare cancer, ocular melanoma, within days ...
Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best get-rich-quick stocks to buy according to hedge funds. On February 24, Iovance Biotherapeutics announced positive early data from a pilot ...
Weight-loss injections like Ozempic may help cancer patients with brain tumours live longer. But experts urge caution before drawing firm conclusions.
Elspeth Davies describes how living with an elevated risk of cancer damaged her relationship with her body, and how she sought to repair it At the age 17 I received a diagnosis of melanoma in situ, ...
Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results